Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 367

2.

Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.

Busch MP, Laycock M, Kleinman SH, Wages JW Jr, Calabro M, Kaplan JE, Khabbaz RF, Hollingsworth CG.

Blood. 1994 Feb 15;83(4):1143-8.

3.

[Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].

Blejer JL, Saguier MC, Salamone HJ, Carreras LA.

Sangre (Barc). 1995 Dec;40(6):447-51. Spanish.

PMID:
8850226
5.

Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil.

Namen-Lopes MS, Martins ML, Drummond PC, Lobato RR; Interdisciplinary HTLV Research Group (GIPH)., Carneiro-Proietti AB.

Transfus Med. 2009 Aug;19(4):180-8. doi: 10.1111/j.1365-3148.2009.00932.x.

PMID:
19706135
6.
7.

Strategies for diagnosis of HTLV-I and -II.

Thorstensson R, Albert J, Andersson S.

Transfusion. 2002 Jun;42(6):780-91.

PMID:
12147033
8.

Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.

Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB.

Am J Trop Med Hyg. 1997 Aug;57(2):142-8.

PMID:
9288805
9.

Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.

Donegan E, Lee H, Operskalski EA, Shaw GM, Kleinman SH, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG, et al.

Transfusion. 1994 Jun;34(6):478-83.

PMID:
8023388
10.

Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil.

Ferreira Júnior OC, Vaz RS, Carvalho MB, Guerra C, Fabron AL, Rosemblit J, Hamerschlak N.

Transfusion. 1995 Mar;35(3):258-63.

PMID:
7878720
11.

Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil.

Jacob F, Santos-Fortuna Ede L, Azevedo RS, Caterino-de-Araujo A.

Rev Inst Med Trop Sao Paulo. 2007 Nov-Dec;49(6):361-4.

12.

Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.

Gutfraind Z, Blejer JL, Saguier MC, Gómez Carretero ML, Pirola DA, Carreras Vescio LA.

Medicina (B Aires). 1995;55(4):295-9.

PMID:
8728867
13.

High seroprevalence of anti-HTLV-I/II antibodies among solid organ donors necessitates confirmatory testing.

Nowicki MJ, Matsuoka L, Brucal D, Chinchilla C, Mone T, Selby R, Mendez R.

Transplantation. 2006 Nov 15;82(9):1210-3.

PMID:
17102773
14.

Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery.

Shih JW, Lee HH, Falchek M, Canavaggio M, Jett BW, Allain JP, Alter HJ.

Blood. 1990 Feb 1;75(3):546-9.

15.
16.

Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.

Kwon SY, Lim AH, Park JY, Han SH, Cho NS.

J Med Virol. 2008 Oct;80(10):1864-7. doi: 10.1002/jmv.21260.

PMID:
18712809
18.

Seroepidemiology of HTLV-I/II in universal screening of blood donations in France.

Couroucé AM, Pillonel J, Lemaire JM, Maniez M, Brunet JB.

AIDS. 1993 Jun;7(6):841-7.

PMID:
8103342
19.

Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.

Tosswill JH, McAlpine L, Mortimer PP.

J Med Virol. 1993 May;40(1):83-5.

PMID:
8099946
20.

Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.

Durojaiye I, Akinbami A, Dosunmu A, Ajibola S, Adediran A, Uche E, Oshinaike O, Odesanya M, Dada A, Okunoye O.

Pan Afr Med J. 2014 Apr 21;17:301. doi: 10.11604/pamj.2014.17.301.4075.

Supplemental Content

Support Center